Lemonade stock price target lowered to $45 by Keefe Bruyette
Keefe Bruyette & Woods lowered its price target on Lemonade Inc. (NYSE:LMND) to $45 from $48, citing higher growth spending and operating expenses. The firm noted Lemonade's premium growth exceeds 30% and revenue grew nearly 70% in the last twelve months. Lemonade reported Q3 2026 earnings, exceeding expectations with revenue of $336.1 million and adjusted loss of $0.56 per share.
How this was made
The 30-second read
Why it matters
The earnings beat and subsequent analyst target cut create mixed signals; earnings support upside while the downgrade suggests downside risk.
Market read
Earnings beat provides short‑term bullish catalyst, but the price‑target cut introduces downside pressure, making the stock a near‑term trade decision.
What to watch
Pet and renters insurance niche may provide resilience not fully captured in the downgrade.
Background
Lemonade reported Q3 2026 results with revenue beating estimates and a narrower loss per share.
Ticker impact
Keefe, Bruyette & Woods lowered Lemonade's price target to $45, citing higher growth spending and operating expenses.
likely pressure as the market prices in the lower valuation
The target reduction reflects concerns over spending and profitability, prompting traders to reassess upside.
Market effects
May weigh on other insurtech and P&C insurers as higher spending concerns spread.
Primarily U.S. market impact; limited regional spillover.
Limited global relevance beyond U.S. fintech/insurtech investors.
Counterpoint
If revenue growth sustains above 30%, the target cut could be premature.
Key entities
- companyLemonade Inc.
U.S. listed insurtech firm (ticker LMND).
- analyst_firmKeefe, Bruyette & Woods
Equity research firm that lowered the price target.
